文献速递湿疹皮炎与荨麻疹

特应性皮炎在线诊疗与面对面诊疗的随机临床试验

Online vs In-Person Care for Atopic Dermatitis: A Randomized Clinical Trial.
PubMed 文献 · JAMA Dermatol · 2026-01-01

该实用随机临床等效性试验纳入300例特应性皮炎患者,1:1随机分至在线团队连接健康(TCH)模式或面对面诊疗。12个月时,两组EASI、POEM和vIGA变化差异均落在预设等效界值内,表明在线TCH模式在改善AD严重度方面与面对面诊疗等效。

要点

  • 在线TCH模式提供异步皮肤科医生评估与治疗建议,12个月EASI改善与面对面诊疗等效。
  • POEM和vIGA变化差异亦在预设等效界值内,支持在线模式用于AD长期管理。
  • 在线协作诊疗或可成为慢性皮肤病如AD的有效管理工具。

核心结论

  • 在线TCH模式在改善AD体征和症状方面与面对面诊疗等效。
  • 远程医疗模式可能成为管理AD等慢性疾病的有效工具。

研究设计与样本

  • 实用随机临床等效性试验,从加州8家门诊皮肤科诊所纳入300例AD患者,2019年8月至2024年5月入组。
  • 患者1:1随机至在线TCH模式(149例)或面对面诊疗(151例),随访12个月。
  • 纳入标准为年龄≥1岁、医生诊断AD、具备网络和照片获取条件、已建立或新就诊的临床诊疗。

主要发现

  • 两组12个月EASI平均变化差异为-0.01(95%CI,-0.22至0.20)。
  • 两组POEM平均变化差异为0.38(95%CI,0.03至0.73)。
  • 两组vIGA平均变化差异为0.06(95%CI,0.00至0.11)。
  • 所有差异均落在预设等效界值内。

关键数值与推荐

  • 主要结局为12个月EASI变化,次要结局为每季度评估的POEM和vIGA变化。
  • 等效性判定依据为各结局组间平均变化差异的95%CI落入预设等效界值。

临床怎么用

  • 在线TCH模式可提供异步皮肤科评估与治疗建议,作为AD长期管理的等效替代方式。
  • 对于具备网络和照片条件的AD患者,可考虑采用在线协作诊疗模式进行随访管理。

局限性

  • 研究仅纳入具备互联网和照片获取条件的患者,可能限制结果外推。
  • 研究在加州8家门诊皮肤科诊所开展,其他地区适用性需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Accessible and effective management of atopic dermatitis (AD) across geographic boundaries is important. Scalable, collaborative care models that integrate patients, primary care practitioners, and specialists remain an unmet need. OBJECTIVE: To determine whether an online, team-based connected health (TCH) model provides equivalent improvements in AD severity compared to in-person care. DESIGN, SETTING, AND PARTICIPANTS: In this pragmatic, randomized clinical equivalence trial, 300 patients with AD were enrolled from 8 outpatient dermatology clinics in California from August 2019 to May 2024 and randomized 1:1 to online or in-person care. Eligible participants were at least 1 year old and had a physician diagnosis of AD, internet and photograph access, and established or new clinician care. INTERVENTION: The TCH model provided asynchronous, online access to dermatologists. Dermatologists reviewed patients' clinical histories and photographs and provided assessments and treatment recommendations online. The control arm provided conventional, in-person care. MAIN OUTCOMES AND MEASURES: The primary outcome was 12-month change in the EASI (Eczema Area and Severity Index); secondary outcomes were changes in the POEM (Patient-Oriented Eczema Measure) and validated vIGA (Investigator Global Assessment), assessed quarterly. RESULTS: Among 300 adults and children with AD (mean [SD] age, 34.6 [17.7] years; 211 [70.3%] female), 149 were assigned to TCH and 151 to in-person care. The difference in mean change between the 2 groups was -0.01 (95% CI, -0.22 to 0.20) for the EASI, 0.38 (95% CI, 0.03-0.73) for the POEM, and 0.06 (95% CI, 0.00-0.11) for the vIGA. All differences fell within prespecified equivalence margins. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, the online TCH model resulted in equivalent improvements in AD signs and symptoms compared to in-person care. Telehealth models may serve as effective tools for managing chronic diseases like AD. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03981926.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Armstrong AW, Roberts AM, Kostandy G, et al. Online vs In-Person Care for Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol. 2026. PMID: 42340708. doi:10.1001/jamadermatol.2026.1959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。